A Significant Proportion of Stage II and III Rectal Cancers, Selected by Precision Magnetic Resonance, Can Safely Be Managed by Upfront Total Mesorectal Excision Surgery Without Neoadjuvant Therapy
Year: 2025
Type: article
Study design: Observational Study
Source: Diseases of the Colon & Rectum
Authors: Laura M. Fernandez, José Moreira Azevedo, Ines Santiago, Mireia Castillo-Martin, Barbara Cardoso, Carlos T. Carvalho, Richard J. Heald, Amjad Parvaiz
Institutions: Champalimaud Foundation, University of Lisbon, Hospital da Luz
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4415508275